Expert highlights importance of Hemovigilance Project

04/14/2010 | HealthLeaders Media

It is crucial for the U.S. to develop a data system on blood transfusion-related adverse events that would be readily available and accessible, making it easier to track these events, said Dr. Paul Ness, editor of the journal Transfusion. The hemovigilance system would provide hospitals with the opportunity to measure whether the changes they make have an effect on patient outcomes.

View Full Article in:

HealthLeaders Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC